AstraZeneca (AZN) reaches an agreement in principle to settle U.S. product liability litigation...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca (AZN) reaches an agreement in principle to settle U.S. product liability litigation over its Seroquel antipsychotic drug for around $198M. The agreement's terms are confidential but are not expected to affect expected 2010 EPS of $6.35-6.65. Shares +0.5%. (PR)